Amicogen, Inc. is a South Korea-based company that operates in the biotechnology, health care, nutrition, and pharmaceutical industries. The company was founded in 2000 and has recently attracted a significant Post-IPO Equity investment on 01 January 2022.
The investment came from Company K Partners and Hyundai Venture Investment Corporation, signifying the confidence that these prominent investors have in Amicogen's potential for growth and innovation.
This recent investment marks a pivotal moment for Amicogen as it continues to make waves in the fields of biotechnology, health care, nutrition, and pharmaceuticals.